Chinese Adults With Kidney Disease
Abroad (travel likely)RecruitingPHASE2
Conditions
Immunoglobulin A Nephropathy (IgAN) · Complement 3 Glomerulopathy (C3G) · IC-MPGN
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ADARx Clinical Site, Shenzhen, Guangdong, China
ADARx Clinical Site, Guiyang, Guizhou, China
ADARx Clinical Site, Zhengzhou, Henan, China
ADARx Clinical Site, Baotou, Inner Mongolia, China
ADARx Clinical Site, Wuxi, Jiangsu, China
ADARx Clinical Site, Yantai, Shandong, China
ADARx Clinical Site, Beijing, China
ADARx Clinical Site, Shandong, China
ADARx Clinical Site, Shanghai, China
ADARx Clinical Site, Shangxi, China
Study leads
Aditya Patel
Study Director
ADARx Pharmaceuticals